ACAD
32.3
-0.16
-0.49%
AEMD
5.35
+0.04
+0.75%
APRI
0.341
-0.011
-3.0467%
ARNA
1.63
+0.04
+2.52%
ATEC
3.6
0.00
0.00%
CNAT
1.94
+0.01
+0.52%
CRXM
0.168
-0.003
-1.754%
CYTX
2.03
-0.04
-1.93%
DXCM
90.62
+0.27
+0.30%
GNMK
8.74
-0.01
-0.11%
HALO
9.55
+0.13
+1.38%
ILMN
169.48
-0.06
-0.04%
INNV
0.4
-0.02
-3.65%
INO
8.67
+0.1
+1.17%
ISCO
1.95
-0.05
-2.50%
ISIS
57.56
0.00
0.00%
LGND
103.65
+1.25
+1.22%
LPTN
2.82
-0.01
-0.35%
MBVX
5.088
-0.012
-0.2431%
MEIP
1.98
+0.01
+0.51%
MNOV
6.42
+0.02
+0.31%
MRTX
4.98
-0.34
-6.39%
MSTX
0.396
-0.006
-1.5908%
NBIX
48.94
-0.5
-1.01%
NUVA
63.39
+0.23
+0.36%
ONCS
1.72
-0.01
-0.58%
ONVO
3.9
+0.1
+2.63%
OREX
3.82
-0.2
-4.98%
OTIC
15.68
-0.53
-3.27%
QDEL
21.42
-0.11
-0.51%
RCPT
231.96
0.00
0.00%
RGLS
3.16
-0.06
-1.86%
RMD
68.44
+0.44
+0.65%
SPHS
3.5
+0.12
+3.55%
SRNE
6.56
+0.13
+2.02%
TROV
4.92
-0.14
-2.77%
VICL
3.85
-0.12
-3.02%
VOLC
18
0.00
0.00%
ZGNX
9.08
+0.2
+2.25%
ACAD
32.3
-0.16
-0.49%
AEMD
5.35
+0.04
+0.75%
APRI
0.341
-0.011
-3.0467%
ARNA
1.63
+0.04
+2.52%
ATEC
3.6
0.00
0.00%
CNAT
1.94
+0.01
+0.52%
CRXM
0.168
-0.003
-1.754%
CYTX
2.03
-0.04
-1.93%
DXCM
90.62
+0.27
+0.30%
GNMK
8.74
-0.01
-0.11%
HALO
9.55
+0.13
+1.38%
ILMN
169.48
-0.06
-0.04%
INNV
0.4
-0.02
-3.65%
INO
8.67
+0.1
+1.17%
ISCO
1.95
-0.05
-2.50%
ISIS
57.56
0.00
0.00%
LGND
103.65
+1.25
+1.22%
LPTN
2.82
-0.01
-0.35%
MBVX
5.088
-0.012
-0.2431%
MEIP
1.98
+0.01
+0.51%
MNOV
6.42
+0.02
+0.31%
MRTX
4.98
-0.34
-6.39%
MSTX
0.396
-0.006
-1.5908%
NBIX
48.94
-0.5
-1.01%
NUVA
63.39
+0.23
+0.36%
ONCS
1.72
-0.01
-0.58%
ONVO
3.9
+0.1
+2.63%
OREX
3.82
-0.2
-4.98%
OTIC
15.68
-0.53
-3.27%
QDEL
21.42
-0.11
-0.51%
RCPT
231.96
0.00
0.00%
RGLS
3.16
-0.06
-1.86%
RMD
68.44
+0.44
+0.65%
SPHS
3.5
+0.12
+3.55%
SRNE
6.56
+0.13
+2.02%
TROV
4.92
-0.14
-2.77%
VICL
3.85
-0.12
-3.02%
VOLC
18
0.00
0.00%
ZGNX
9.08
+0.2
+2.25%
Home » Events

Label-Free Symposium

Submitted by on July 14, 2009 – 2:47 pm

Advances and challenges in label-free technologies for drug discovery

November 2-3, 2009

San Diego, CA

[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *
Time limit is exhausted. Please reload CAPTCHA.